Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-02-03 @ 5:47 PM
Study NCT ID:
NCT05043103
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-03
First Post:
2021-07-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients with Advanced Parkinson's Disease
Sponsor:
Britannia Pharmaceuticals Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Parkinson Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Parkinson´s Disease | View |
| None | Movement Disorders | View |
| None | Levodopa | View |
| None | Entacapone | View |
| None | Carbidopa Levodopa drug combination | View |
| None | Antiparkinson Agents | View |
| None | Anti-Dyskinesia-Agents | View |
| None | Dopamine Agents | View |
| None | Dopamine Agonists | View |
| None | Catechol-O-methyltransferase (COMT) inhibitor | View |
| None | Portable Pump | View |
| None | Gel | View |
| None | Quality of Life | View |